Philip A. Pizzo is Director of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 9,112 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Philip A. Pizzo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2022
SELL
Sale (or disposition) back to the issuer
-
9,112 Reduced 100.0%
0 Common Stock
Jun 21 2022
SELL
Open market or private sale
$34,335 $27.25 p/Share
1,260 Reduced 12.15%
9,112 Common Stock
Jun 14 2022
BUY
Exercise of conversion of derivative security
-
3,600 Added 25.77%
10,372 Common Stock
Jun 18 2021
SELL
Open market or private sale
$38,915 $36.54 p/Share
1,065 Reduced 13.59%
6,772 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
-
3,037 Added 27.93%
7,837 Common Stock
PAP

Philip A. Pizzo

Director
South San Francisco, CA

Track Institutional and Insider Activities on GBT

Follow Global Blood Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT